Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii in H. pylori Quadruple Therapy
NCT03997279Phase 4Unknown
- Sponsor
- University Clinical Center of Serbia
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Microbiome Therapeutics
01
Overview
A Phase 4 trial of saccharomyces boulardii in Helicobacter pylori infection, sponsored by University Clinical Center of Serbia. Status: unknown.
02
Drugs
saccharomyces boulardii
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03997279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03997279.